Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent Prostate Cancer”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Testing effectiveness (Phase 2)Study completedNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Testing effectiveness (Phase 2)Study completedNCT03315871
What this trial is testing

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT05946824
What this trial is testing

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Who this might be right for
Recurrent Prostate Cancer After Surgery
University of Rochester 80
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Testing effectiveness (Phase 2)Study completedNCT04733768
What this trial is testing

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alberta 100
Large-scale testing (Phase 3)Study completedNCT00089674
What this trial is testing

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 1,468
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Not applicableStudy completedNCT04400656
What this trial is testing

PROState Pathway Embedded Comparative Trial

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer+3 more
Imperial College London 139
Early research (Phase 1)Study completedNCT00629057
What this trial is testing

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

Who this might be right for
Androgen-insensitive Prostate Cancer
Bavarian Nordic 24
Not applicableStudy completedNCT01118741
What this trial is testing

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00908141
What this trial is testing

GM-CSF in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009967
What this trial is testing

Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Early research (Phase 1)Ended earlyNCT00313534
What this trial is testing

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Study completedNCT00174863
What this trial is testing

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sanofi 232
Next Page